New study shows a minimum dose of hydromethylthionine could slow cognitive decline

ABERDEEN, Scotland and Singapore, 26 November, 2019 – In a paper published in today’s online issue of the Journal of Alzheimer’s Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients…

Black silicon can help detect explosives

Scientists from Far Eastern Federal University (FEFU), Far Eastern Branch of the Russian Academy of Sciences, Swinburne University of Technology, and Melbourne Center for Nanofabrication developed an ultrasensitive detector based on black silicon. The device is able to detect trace amounts of nitroaromatic compounds and can be applied to identify the majority of explosives or…

New vaccine will stop the spread of bovine TB

Scientists at the University of Surrey have developed a novel vaccine and complementary skin test to protect cattle against bovine tuberculosis (bovine TB). Publishing their findings in the journal Scientific Reports, researchers reveal they have for the first time created a vaccine that is compatible with a synthetic form of the tuberculin skin test (PPD),…

Head-to-head comparison finds three anti-seizure drugs equally effective for severe form of epilepsy

ANN ARBOR, Mich. – A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective. Status epilepticus is characterized by individual seizures or multiple seizures close together lasting more than five minutes with a loss of consciousness. If…

Activation of opioid receptor uncovered

Together with colleagues from Shanghai, Brussels, Canada and the USA, researchers from the University of Bonn have uncovered the binding mechanism of an important pain receptor. The results facilitate the development of new active substances. The opioids used today to treat severe pain can be addictive and sometimes have life-threatening side effects. The results are…

Four UIC researchers recognized as AAAS fellows

The American Association for the Advancement of Science, or AAAS, recognizes individuals as AAAS fellows for their advances of science applications that are regarded as scientifically or socially distinguished. Of the 443 fellows this year, four were awarded to researchers from the University of Illinois at Chicago. UIC researchers elected as AAAS fellows are Isabel…

New strategy for treating the most aggressive type of brain cancer is tested at USP

Researchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain cancer in adults that combines a photoactive molecule and a chemotherapeutic agent – both encapsulated in protein-lipid nanoparticles. Results of the research, supported by São Paulo Research Foundation – FAPESP, were presented during…